Skip to main content
. 2010 May 7;28(21):3741–3747. doi: 10.1016/j.vaccine.2010.02.067

Table 3.

The number of peptides and mean titers of the total IgG anti-Msp2 specific antibody response after immunization and after challenge.

Immunogen Animal ID Immunizeda
Bacteremia
CR
HVR
# peptides recognizedb Mean (Max) titerc # peptides recognized Mean (Max) titer Max. % infected RBCs
Complexes 5933 6 145 (640) 14 374 (1280) 4.5%
Complexes 5961 2 60 (640) 7 277 (1280) 3.4%
Complexes 5972 1 10 (10) 12 32 (80) 2.7%
Complexes 5946 4 210 (640) 13 222 (640) Protectedd
Complexes 5952 5 232 (640) 12 225 (640) Protected



Mean 2.8 131 11.6 226



Outer membranes 5953 3 440 (640) 16 338 (1280) 6.4%
Outer membranes 5966 2 45 (80) 12 43 (160) 2.4%
Outer membranes 5978 3 30 (40) 14 40 (40) 1.7%
Outer membranes 5982 1 320 (320) 12 205 (320) Protected
Outer membranes 5975 1 20 (20) 8 330 (640) Protected



Mean 2.0 171 12.4 191



Infectede
 Adjuvant 5969 2 30 (40) 16 365 (1280) 31.0%
 Adjuvant 5967 3 30 (40) 12 1030 (5120) 19.0%
 Adjuvant 5958 1 80 (80) 10 412 (1280) 10.8%
 Adjuvant 5979 3 120 (320) 15 251 (1280) 10.3%
 Adjuvant 5974 2 165 (320) 11 470 (1280) 5.3%



Mean 2.2 85 12.8 506
a

Specific antibody response measured after the final immunization and prior to challenge.

b

The number of peptides recognized from either the CR or HVR at a 1:10 serum dilution.

c

The mean of the titers for all peptides recognized by each serum sample. The maximum titer for each serum sample is reported in parentheses.

d

Protected from infection as defined by negative PCR and repeated negative blood smears.

e

Specific antibody response measured 45 days after infection with A. marginale.